Sihuan Pharmaceutical Holdings Group Ltd. (SHPHF)

USD 0.05

(0.0%)

Market Cap (In USD)

455.3 Million

Revenue (In USD)

1.86 Billion

Net Income (In USD)

-54.01 Million

Avg. Volume

-

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.045-0.095
PE
-
EPS
-
Beta Value
0.576
ISIN
BMG8162K1137
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Dr. Weicheng Guo
Employee Count
-
Website
https://www.sihuanpharm.com
Ipo Date
2012-01-13
Details
Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in the People's Republic of China. It offers drugs in the oncology, metabolic diseases, digestive system, and other therapeutic areas. The company is also involved in the investment and sale of medical beauty products; manufacture of medical instruments; investment in properties; construction for medical projects; and project preparation for pharmaceutical products manufacturing. In addition, it provides information support, general hospital, hospital management, biotechnology promotion, and medical aesthetic research and development services. The company was founded in 2001 and is based in Wanchai, Hong Kong.